Cargando…

Identification of RCC Subtype-Specific microRNAs–Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data

SIMPLE SUMMARY: In the majority of renal cancer cases, the disease course is non-symptomatic which frequently leads to late diagnosis of disease. Currently, there are no molecular tools dedicated to the detection and monitoring of renal cancer. Our study aimed to investigate changes in microRNA (miR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kajdasz, Arkadiusz, Majer, Weronika, Kluzek, Katarzyna, Sobkowiak, Jacek, Milecki, Tomasz, Derebecka, Natalia, Kwias, Zbigniew, Bluyssen, Hans A. R., Wesoly, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867039/ https://www.ncbi.nlm.nih.gov/pubmed/33535553 http://dx.doi.org/10.3390/cancers13030548

Ejemplares similares

Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA
por: Kluzek, Katarzyna, et al.
Publicado: (2017)

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors
por: Wrzesiński, Tomasz, et al.
Publicado: (2015)

Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell Carcinoma
por: Majer, Weronika, et al.
Publicado: (2015)

Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models
por: Filipiak-Duliban, Aleksandra, et al.
Publicado: (2022)

Molecular subtypes and prognosis in RCC
por: Beuselinck, Benoit, et al.
Publicado: (2015)

MicroRNA-331-3p inhibits proliferation and metastasis of ovarian cancer by targeting RCC2
por: Buranjiang, Gulimire, et al.
Publicado: (2018)

Identification of key genes of the ccRCC subtype with poor prognosis
por: Puzanov, Grigory Andreevich
Publicado: (2022)

The epigenetic landscape of clear-cell renal cell carcinoma
por: Kluzek, Katarzyna, et al.
Publicado: (2015)

A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC
por: Piao, Xuan-Mei, et al.
Publicado: (2023)

Open Surgery for Localized RCC
por: Vander Eeckt, Kathy, et al.
Publicado: (2007)

FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression data
por: Zodro, Elżbieta, et al.
Publicado: (2013)

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC
por: Liu, Xiaoyan, et al.
Publicado: (2019)

Lipid Stores and Lipid Metabolism Associated Gene Expression in Porcine and Bovine Parthenogenetic Embryos Revealed by Fluorescent Staining and RNA-seq
por: Kajdasz, Arkadiusz, et al.
Publicado: (2020)

Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics
por: Oliveira, Rita de Cássia, et al.
Publicado: (2017)

Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017)

The Multifaceted Roles of RCC1 in Tumorigenesis
por: Ren, Xuanqi, et al.
Publicado: (2020)

The use of luteinizing hormone-releasing hormone analogues is still an indispensable element of therapy in castrate-resistant prostate cancer
por: Milecki, Tomasz, et al.
Publicado: (2014)

Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?
por: Milecki, Tomasz, et al.
Publicado: (2015)

Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model
por: Yuen, J S P, et al.
Publicado: (2011)

Risk of infections in renal cell carcinoma (RCC) and non-RCC patients treated with mammalian target of rapamycin inhibitors
por: Kaymakcalan, M D, et al.
Publicado: (2013)

Expression of microRNA-30c via lentivirus vector inhibits the proliferation and enhances the sensitivity of highly aggressive ccRCC Caki-1 cells to anticancer agents
por: Yang, Honglin, et al.
Publicado: (2017)

Isolated Scalp Nodule in Patient with Undiagnosed RCC
por: Pan, David, et al.
Publicado: (2006)

Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
por: Grünwald, V., et al.
Publicado: (2022)

Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC)
por: Rysz, Jacek, et al.
Publicado: (2021)

Computation of ionization-load in the traditional TPC and the RCC readout
por: Fischer, H G, et al.
Publicado: (1997)

The Contributions of HIF-Target Genes to Tumor Growth in RCC
por: Zhang, Ting, et al.
Publicado: (2013)

Study of Treatment Outcome in Adults with TFE-Related RCC
por: Singh, Ajaykumar Chandrabhan, et al.
Publicado: (2021)

Agent-Based Learning Model for the Obesity Paradox in RCC
por: Belenchia, Matteo, et al.
Publicado: (2021)

Functional and translational consequences of immunometabolic coevolution in ccRCC
por: Reznik, Ed, et al.
Publicado: (2023)

Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro
por: Zieren, Richard C., et al.
Publicado: (2021)

Co-Expression of Multiple PAX Genes in Renal Cell Carcinoma (RCC) and Correlation of High PAX Expression with Favorable Clinical Outcome in RCC Patients
por: Li, Lei, et al.
Publicado: (2023)

CD44 Is Associated with Poor Prognosis of ccRCC and Facilitates ccRCC Cell Migration and Invasion through HAS1/MMP9
por: Du, Tan, et al.
Publicado: (2023)

Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?
por: Shah, Amishi Y., et al.
Publicado: (2015)

Lesions in the Larynx of Wistar RccHan(TM): WIST Rats
por: Weber, Klaus, et al.
Publicado: (2009)

Crossing Paths in Human Renal Cell Carcinoma (hRCC)
por: Gallego, Guadalupe Aparicio, et al.
Publicado: (2012)

Vimentin 3, the New Hope, Differentiating RCC versus Oncocytoma
por: von Brandenstein, Melanie, et al.
Publicado: (2015)

RCC prolapse causing Aortic regurgitation in a restrictive VSD
por: Abqari, S, et al.
Publicado: (2015)

Tumor size, stage and grade alterations of urinary peptidome in RCC
por: Chinello, Clizia, et al.
Publicado: (2015)

Toxicity of Checkpoint Inhibition in Advanced RCC: A Systematic Review
por: Ornstein, Moshe C., et al.
Publicado: (2017)

Compare Fuhrman Nuclear and Chromophobe Tumor Grade on Chromophobe RCC
por: Lin, Tsu-Feng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v491gde0tcncgsnuu40afn2irp